Sumitomo Dainippon Pharma Co. in Japan and US-based behavioural health firm BehaVR have signed definitive agreements to develop and market general wellness products and prescription digital therapeutics for the treatment of major mental health disorders.
WHAT IT'S ABOUT
Sumitomo Dainippon Pharma is engaged in the research and development of new pharmaceutical products in the areas of psychiatry...
